1. Home
  2. GSK vs CI Comparison

GSK vs CI Comparison

Compare GSK & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSK
  • CI
  • Stock Information
  • Founded
  • GSK 1715
  • CI 1792
  • Country
  • GSK United Kingdom
  • CI United States
  • Employees
  • GSK N/A
  • CI N/A
  • Industry
  • GSK Biotechnology: Pharmaceutical Preparations
  • CI Medical Specialities
  • Sector
  • GSK Health Care
  • CI Health Care
  • Exchange
  • GSK Nasdaq
  • CI Nasdaq
  • Market Cap
  • GSK 86.1B
  • CI 89.2B
  • IPO Year
  • GSK N/A
  • CI N/A
  • Fundamental
  • Price
  • GSK $38.04
  • CI $314.34
  • Analyst Decision
  • GSK Hold
  • CI Strong Buy
  • Analyst Count
  • GSK 3
  • CI 17
  • Target Price
  • GSK N/A
  • CI $386.76
  • AVG Volume (30 Days)
  • GSK 4.9M
  • CI 1.6M
  • Earning Date
  • GSK 07-30-2025
  • CI 07-31-2025
  • Dividend Yield
  • GSK 4.23%
  • CI 1.92%
  • EPS Growth
  • GSK N/A
  • CI 46.10
  • EPS
  • GSK 0.98
  • CI 17.99
  • Revenue
  • GSK $40,735,668,430.00
  • CI $255,368,000,000.00
  • Revenue This Year
  • GSK $6.70
  • CI $7.18
  • Revenue Next Year
  • GSK $5.42
  • CI $4.16
  • P/E Ratio
  • GSK $18.78
  • CI $17.46
  • Revenue Growth
  • GSK 2.57
  • CI 23.96
  • 52 Week Low
  • GSK $31.72
  • CI $262.03
  • 52 Week High
  • GSK $44.67
  • CI $370.83
  • Technical
  • Relative Strength Index (RSI)
  • GSK 40.16
  • CI 47.97
  • Support Level
  • GSK $40.67
  • CI $311.08
  • Resistance Level
  • GSK $42.63
  • CI $318.71
  • Average True Range (ATR)
  • GSK 0.66
  • CI 5.40
  • MACD
  • GSK -0.41
  • CI 0.68
  • Stochastic Oscillator
  • GSK 4.67
  • CI 51.51

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About CI The Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

Share on Social Networks: